Showing 861-870 of 7547 results for "".
Metabolomics Highlights: The Importance of Circadian Rhythm in Skin
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/metabolomics-highlights-the-importance-of-circadian-rhythm-in-skin/23126/New insights on the critical role of maintaining the natural rhythm of skin protection and repair.Galderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million dUnderstanding the Role of Herbs in Cosmeceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/understanding-the-role-of-herbs-in-cosmeceuticals/20445/A unique herb blend in cosmeceuticals has shown clinical superiority over antioxidant and growth factor products.Exploring Hydrochlorothiazide Use and Skin Cancer Risk
https://practicaldermatology.com/topics/skin-cancer-photoprotection/exploring-hydrochlorothiazide-use-and-skin-cancer-risk/20446/A commonly used antihypertensive appears to be linked to an increased risk of SCC. What should dermatologists do?Utilize User Generated Content for your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/utilize-user-generated-content-for-your-dermatology-practice/20457/When patients participate in content creation, engagement may increase.ABD Eyes Mohs Certification, Sun's Ilumya Approved, FUE Update
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abd-eyes-mohs-certification-sun-s-ilumya-approved-fue-update/18319/The American Board of Dermatology has notified the American Board of Medical Specialties it wants to offer a subspecialty certificate in Micrographic Dermatologic Surgery. Dermatologists react. Ilumya or tildrakizumab from Sun Pharma is approved for moderate to severe psoriasis. Medicine the MusicalPhysician Spotlight: Jody Comstock, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-jody-comstock-md-phd/20525/Exploring the role of physician assistants in cosmetic dermatology.How to Convince an Online Influencer to Promote Your Practice
https://practicaldermatology.com/topics/practice-management/how-to-convince-an-online-influencer-to-promote-your-practice/20750/An online influencer can make a strong impact and boost the prospects of your practice in the online world.To Be Shorr: Use Call Tracking Numbers to Measure Your Marketing ROI
https://practicaldermatology.com/topics/practice-management/to-be-shorr-use-call-tracking-numbers-to-measure-your-marketing-roi/18604/Tracking ROI on your marketing initiatives is an important but sometimes challenging undertaking. In this edition of "To Be Shorr," Mara Shorr, BS, CAC II-V shares tips for easily tracking your investments, including the use of call tracking numbers.How do you manage a complex medical referral?
https://practicaldermatology.com/topics/practice-management/how-do-you-manage-a-complex-medical-referral-/18794/Management of complex medical dermatology referrals has evolved, says Joseph Jorizzo, MD, FAAD, Professor; Former & Founding Chair, Dermatology Dept., Wake Forest University and Professor of Dermatology, Weill Cornell Medical College. In this edition of Ask an Expert, he talks to host Adam Fried